fda tirzepatide shortage says the weight-loss drug is over FDA removes Lilly's Mounjaro and

The doctor can prescribe multiple tests to determine the condition's underlying cause and severity

Some people report mood changes, anxiety, or depression when using semaglutide

What's new in 2026 is the compounding classification review driven by the February 27, 2026 RFK Jr announcement and formalized at the July 23-24, 2026 Pharmacy Compounding Advisory Committee meeting

Understanding how to manage these medications together ensures safe, effective treatment when infections arise

A look at Big Pharma's new rival Multiple pharmacists who spoke to the Chronicle said its difficult to know the potential health consequences of using injectables made with food grade products because those formulations havent been tested as part of an FDA-approved study